Novel approaches to treatment of generalized anxiety disorder

Current Opinion in Psychiatry

Volumn 23, Issue 1, 2010, Pages 37-42

  Allgulander, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amygdala; Anxiety disorders; Cognition; Cognitive therapy; Guideline; Sleep initiation and maintenance disorders

Indexed keywords

ALPRAZOLAM; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CITALOPRAM; DIAZEPAM; DULOXETINE; ESCITALOPRAM; ESZOPICLONE; HYDROXYZINE; IMIPRAMINE; OLANZAPINE; PAROXETINE; PREGABALIN; QUETIAPINE; RISPERIDONE; SERTRALINE; VENLAFAXINE; ZOLPIDEM;

ANXIETY DISORDER; CLINICAL FEATURE; COGNITIVE THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; EXTRAPYRAMIDAL SYNDROME; GENERALIZED ANXIETY DISORDER; HUMAN; INSOMNIA; INTERNATIONAL CLASSIFICATION OF DISEASES; LOW DRUG DOSE; MAJOR DEPRESSION; MUSCLE RELAXATION; PANIC; PATIENT SAFETY; PRACTICE GUIDELINE; PSYCHOTHERAPY; REVIEW; SOCIAL PHOBIA; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RELAXATION THERAPY;

EID: 74349123074     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e328333d574     Document Type: Review

References (42)

1. Allgulander C. Generalized anxiety disorder (GAD): between now and DSMV. Psychiatr Clin North Am 2009; 32:611-628.
2. Bandelow B, Zohar J, Kasper S, Möller H-J. How to grade categories of evidence. World J Biol Psychiatry 2008; 9:242-247.
3. Bandelow B, Zohar J, Hollander E, et al., WFSBP task force on treatment guidelines for anxiety obsessive-compulsive posttraumatic stress disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders: first revision. World J Biol Psychiatry 2008; 9:248-312.
4. Nutt DJ, Malizia AL. Why does the world have such a 'down' on antidepressants? J Psychopharmacol 2008; 22:223-226.
5. Löwe B, Spitzer RL, Williams JBW, et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 2008; 30:191-199.
6. Kato K, Sullivan PF, Evengå rd B, Pedersen NL. A population-based twin study of functional somatic syndromes. Psychol Med 2009; 39:497-505.
7. Gao K, Sheehan DV, Calabrese JR. Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders. Expert Rev Neurother 2009; 9:1147-1158.
8. Donovan MR, Glue P, Kolluri S, Emir B. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders: a meta-analysis. J Affect Disord 2009. doi: 10.1016/j.jad.2009.06.021.
9. Davidson JR, Zhang W, Connor KM, et al. A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). J Psychopharmacol 2008. doi:10.1177/0269881108096505.
10. Seekles W, van Straten A, Beekman A, et al. Stepped care for depression and anxiety: from primary care to specialized mental healthcare-a randomised controlled trial testing the effectiveness of a stepped care program among primary care patients with mood or anxiety disorders. BMC Health Serv Res 2009; 9:90. doi:10.1186/1472-6963-9-90.
11. Craske MG, Roy-Byrne PP, Stein MB, et al. Treatment for anxiety disorders: efficacy to effectiveness to implementation. Behav Res Ther 2009. doi: 10.1016/j.brat.2009.07.012.
12. Behar E, DiMarco ID, Hekler EB, et al. Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications. J Anxiety Disord 2009; 23:1011-1023.
13. Allen LB, McHugh RK, Barlow DH. Emotional disorders. A unified protocol. In: Barlow DH, editor. Clinical handbook of psychological disorders. New York: The Guilford Press; 2008.
14. Leichsenring F, Salzer S, Jaeger U, et al. Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial. Am J Psychiatry 2009; 166:875-881.
15. Hunot V, Churchill R, Teixeira V, Silva de Lima M. Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Rev 2007: CD001848.
16. Covin R, Ouimet AJ, Seeds PM, Dozois DJA. A meta-analysis of CBT for pathological worry among clients with GAD. J Anxiety Disord 2008; 22:108-116.
17. Hofman SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized controlled trials. J Clin Psychiatry 2008; 69:621-632.
18. Statens beredning för medicinsk utvärdering (SBU). Behandling av å ngestsyndrom. Rapport 2005.
19. Allgulander C, Cloninger CR, Przybeck TR, Brandt L.Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder. Psychopharmacol Bull 1998; 34:165-166.
20. Nutt D, Allgulander C, Lecrubier Y, et al. Establishing noninferiority in treatment trials in psychiatry. Guidelines from an expert consensus meeting. J Psychopharmacol 2008; 22:409-416.
21. Hofman SG, Sawyer AT, Korte KJ, Smits JAJ. Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review. Int J Cogn Ther 2009; 2:160-175.
22. Pollack MH. Refractory generalized anxiety disorder. J Clin Psychiatry 2009; 70 (Suppl 2):32-38.
23. Allgulander C, Jörgensen T, Wade A, et al. Health-related quality of life (HRQOL) among patients with generalised anxiety disorder: evaluation conducted alongside an escitalopram relapse prevention trial. Curr Med Res Opin 2007; 23:2543-2549.
24. Pollack MH, Endicott J, Liebowitz M, et al. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res 2008; 42:1042-1049.
25. Bereza BG, Machado M, Einarson TR. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder. Clin Ther 2009; 31:1279-1308.
26. Hidalgo RB, Tupler LA, Davidson JRT. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol 2007; 21:864-872.
27. Feltner D, Wittchen H-U, Kavoussi R, et al. Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol 2008; 23:18-28.
28. Nitschke JB, Sarinopoulos I, Oathes DJ, et al. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 2009; 166:302-310.
29. Pollack M, Kinrys G, Krystal A, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 2008; 65:551-562.
30. Brenes GA, Miller ME, Stanley MA, et al. Insomnia in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry 2009; 17:465-472.
31. Fava M, Asnis GM, Shrivastava R, et al. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. J Clin Psychopharmacol 2009; 29:222-230.
32. Hopkins SC, Curry L, Dunn J, et al. Evaluation of low-dose eszopiclone on anxiolytic and sedative activity. Poster, ADAA, Albuquerque; 12-15 March 2009.
33. Montgomery SA, Herman BK, Schweizer E, Mandel FS. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia. Int Clin Psychopharmacol 2009; 24:214-222.
34. Bryant C, Jackson H, Ames D. The prevalence of anxiety in older adults: methodological issues and a review of the literature. J Affect Disord 2008; 109:233-250.
35. Mohlman J, Price RB, Eldreth DA, et al. The relation of worry to prefrontal cortex volume in older adults with and without generalized anxiety disorder. Psychiatr Res Neuroimag 2009; 17:121-127.
36. Stanley MA, Wilson NL, Novy DM, et al. Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care. A randomized clinical trial. JAMA 2009; 301:1460-1467.
37. Chou K-L. Age at onset of generalized anxiety disorder in older adults. Am J Geriatr Psychiatry 2009; 17:455-464.
38. Porensky EK, Dew MA, Karp JF, et al. The burden of late-life generalized anxiety disorder: effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry 2009; 17:473-482.
39. Lenze EJ, Rollman BL, Shear MK, et al. Escitalopram for older adults with generalized anxiety disorder. A randomized controlled trial. JAMA 2009; 301:295-303.
40. Davidson J, Allgulander C, Pollack MH, et al. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized double-blind, placebo-controlled studies. Hum Psychopharmacol 2008; 23:519-526.
41. Montgomery S, Chatamra K, Pauer L, et al. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. Br J Psychiatry 2008; 193: 389-394.
42. Möller H-J. Development of DSM-V and ICD-11: tendencies and potential of new classifications in psychiatry at the current state of knowledge. Psychiatry Clin Neurosci 2009; 63:595-612.